Notice2025-02542
Mattresses From Serbia: Rescission of Antidumping Duty Administrative Review; 2023-2024
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 12, 2025
Issuing agencies
Commerce DepartmentInternational Trade Administration
Abstract
The U.S. Department of Commerce (Commerce) is rescinding the administrative review of the antidumping duty (AD) order on mattresses from Serbia for the period of review (POR) May 1, 2023, through April 30, 2024.
Full Text
<html>
<head>
<title>Federal Register, Volume 90 Issue 28 (Wednesday, February 12, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 28 (Wednesday, February 12, 2025)]
[Notices]
[Pages 9412-9413]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-02542]
[[Page 9412]]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
International Trade Administration
[A-801-002]
Mattresses From Serbia: Rescission of Antidumping Duty
Administrative Review; 2023-2024
AGENCY: Enforcement and Compliance, International Trade Administration,
Department of Commerce.
SUMMARY: The U.S. Department of Commerce (Commerce) is rescinding the
administrative review of the antidumping duty (AD) order on mattresses
from Serbia for the period of review (POR) May 1, 2023, through April
30, 2024.
DATES: Applicable February 12, 2025.
FOR FURTHER INFORMATION CONTACT: Tyler Weinhold, AD/CVD Operations,
Office VI, Enforcement and Compliance, International Trade
Administration, U.S. Department of Commerce, 1401 Constitution Avenue
NW, Washington, DC 20230; telephone: (202) 482-1121.
SUPPLEMENTARY INFORMATION:
Background
On May 2, 2024, Commerce published in the Federal Register a notice
of opportunity to request an administrative review of the AD order on
mattresses from Serbia.\1\ Commerce received a timely request for
review of the Order from Healthcare Europe DOO Ruma for itself, and
from Brooklyn Bedding, Elite Comfort Solutions, FXI, Inc., Kolcraft
Enterprises, Inc., Leggett & Platt, Incorporated, the International
Brotherhood of Teamsters, and United Steel, Paper and Forestry, Rubber,
Manufacturing, Energy, Allied Industrial and Service Workers
International Union, AFL-CIO (the petitioners) for Healthcare Europe,
Inc.\2\ We received no other requests of review.
---------------------------------------------------------------------------
\1\ See Antidumping or Countervailing Duty Order, Finding, or
Suspended Investigation; Opportunity to Request Administrative
Review and Join Annual Inquiry Service List, 89 FR 35778, 35779 (May
2, 2024); see also Mattresses from Cambodia, Indonesia, Malaysia,
Serbia, Thailand, the Republic of Turkey, and the Socialist Republic
of Vietnam: Results of Antidumping Duty Orders and Final Affirmative
Antidumping Determination for Cambodia, 86 FR 26460 (May 14, 2021)
(Order).
\2\ See Healthcare's Letter, ``Request for Administrative Review
of Healthcare Europe DOO Ruma,'' dated May 31, 2024; see also
Petitioners' Letter, ``Request for Administrative Review of
Antidumping Duty Order,'' dated May 31, 2024.
---------------------------------------------------------------------------
On July 5, 2024, Commerce initiated an administrative review of the
AD order on mattresses from Serbia, covering the period from May 1,
2023, through April 30, 2024, in accordance with section 751(a) of the
Tariff Act of 1930, as amended (the Act), and 19 CFR
351.221(c)(1)(i).\3\ This review covers subject merchandise exported
and/or produced by the following two companies: (1) Healthcare Europe
DOO Ruma.; and (2) Healthcare Europe, Inc.\4\ On July 22, 2024, we
placed on the record U.S. Customs and Border Protection (CBP) data for
entries of mattresses from Serbia during the POR, showing no reviewable
POR entries for one company, Healthcare Europe Inc. listed in the
Initiation Notice.\5\ We invited interested parties to comment, and
received no comments. Commerce issued the initial questionnaire to
Healthcare Europe DOO Ruma.\6\ On September 30, 2024, Healthcare Europe
DOO Ruma withdrew its request for administrative review, pursuant to 19
CFR 351.213(d)(1).
---------------------------------------------------------------------------
\3\ See Initiation of Antidumping and Countervailing Duty
Administrative Reviews, 89 FR 55567 (July 5, 2024).
\4\ Id., 89 FR at 55573.
\5\ See Memorandum, ``Release of U.S. Customs and Border
Protection Import Data,'' dated July 22, 2024.
\6\ See Commerce's Letter, ``Initial Antidumping Duty
Questionnaire,'' dated August 28, 2024.
---------------------------------------------------------------------------
On November 19, 2024, Commerce notified all interested parties of
its intent to rescind the administrative review because there were no
suspended entries of subject merchandise made by Healthcare Europe,
Inc., and invited interested partes to comment.\7\ We received comments
filed on behalf of Healthcare Europe DOO Ruma.\8\ Healthcare Europe DOO
Ruma agreed with Commerce's stated intent to rescind the administrative
review with respect to Healthcare Europe, Inc., and also reiterated
that it timely withdrew its review request of itself, and as a result,
Commerce should rescind the administrative review with respect to
Healthcare Europe DOO Ruma.\9\ Commerce did not receive comments from
any other interested parties on Commerce's notice of intent to rescind
the administrative review.
---------------------------------------------------------------------------
\7\ See Memorandum, ``Intent to Rescind Review,'' dated November
19, 2024.
\8\ See Healthcare's Letter, ``Comments on Notice of Intent to
Rescind Administrative Review,'' dated November 26, 2024.
\9\ Id.
---------------------------------------------------------------------------
On July 22, 2024, Commerce tolled certain deadlines in this
administrative proceeding by seven days.\10\ On December 9, 2024,
Commerce tolled certain deadlines in this administrative proceeding by
an additional 90 days.\11\
---------------------------------------------------------------------------
\10\ See Memorandum, ``Tolling of Deadlines for Antidumping and
Countervailing Duty Proceedings,'' dated July 22, 2024.
\11\ See Memorandum, ``Tolling of Deadlines for Antidumping and
Countervailing Duty Proceedings,'' dated December 9, 2024.
---------------------------------------------------------------------------
Rescission of Review
Pursuant to 19 CFR 351.213(d)(1), Commerce will rescind an
administrative review, in whole or in part, if the parties that
requested a review withdraw the request within 90 days of the date of
publication of the notice of initiation. Commerce received a request
from Healthcare Europe DOO Ruma for an administrative review of itself.
On September 30, 2024, Healthcare Europe DOO Ruma withdrew its request
for a review of itself.\12\ Because the request for review was timely
withdrawn for Healthcare Europe DOO Ruma, and because no other party
requested a review of Healthcare Europe DOO Ruma, in accordance with 19
CFR 351.213(d)(1), Commerce is rescinding this review for Healthcare
Europe DOO Ruma.
---------------------------------------------------------------------------
\12\ See Healthcare's Letter, ``Withdrawal of Request for
Administrative Review,'' dated September 30, 2024.
---------------------------------------------------------------------------
Pursuant to 19 CFR 351.213(d)(3), it is Commerce's practice to
rescind an administrative review of an AD order when there are no
entries of subject merchandise during the POR for which liquidation is
suspended.\13\ Normally, upon completion of an administrative review,
the suspended entries are liquidated at the AD assessment rate
calculated for the review period.\14\ Therefore, for an administrative
review to be conducted, there must be a suspended entry that Commerce
can instruct CBP to liquidate at the AD assessment rate calculated for
the review period.\15\ As noted above, there were no suspended entries
of subject merchandise for Healthcare Europe, Inc. subject to this
review during the POR. Accordingly, in the absence of suspended entries
of subject merchandise during the POR, we are hereby rescinding this
administrative review, in its entirety, in accordance with 19 CFR
351.213(d)(3).
---------------------------------------------------------------------------
\13\ See, e.g., Dioctyl Terephthalate from the Republic of
Korea: Rescission of Antidumping Administrative Review; 2021-2022,
88 FR 24758 (April 24, 2023); see also Certain Carbon and Alloy
Steel Cut-to-Length Plate from the Federal Republic of Germany:
Recission of Antidumping Administrative Review; 2020-2021, 88 FR
4154 (January 24, 2023).
\14\ See 19 CFR 351.212(b)(1).
\15\ See 19 CFR 351.213(d)(3).
---------------------------------------------------------------------------
Cash Deposit Requirements
As Commerce has proceeded to a final rescission of this
administrative review, no cash deposit rates will change. Accordingly,
the current cash deposit requirements shall remain in effect until
further notice.
[[Page 9413]]
Assessment
Commerce will instruct CBP to assess antidumping duties on all
appropriate entries of mattresses from Serbia. Antidumping duties shall
be assessed at rates equal to the cash deposit rate of estimated
antidumping duties required at the time of entry, or withdrawal from
warehouse, for consumption, in accordance with 19 CFR 351.212(c)(1)(i).
Commerce intends to issue appropriate assessment instructions to CBP no
earlier than 35 days after the date of publication of this rescission
notice in the Federal Register.
Administrative Protective Order (APO)
This notice serves as a final reminder to parties subject to an APO
of their responsibility concerning the return or destruction of
proprietary information disclosed under APO in accordance with 19 CFR
351.305(a)(3), which continues to govern business proprietary
information in this segment of the proceeding. Timely written
notification of the return or destruction of the APO materials, or
conversion to judicial protective order is hereby requested. Failure to
comply with regulations and terms of an APO is a violation, which is
subject to sanction.
Notification to Interested Parties
We are issuing and publishing this notice in accordance with
sections 751(a)(1) and 777(i)(1) of the Act, and 19 CFR 351.213(d)(4).
Dated: February 7, 2025.
Scot Fullerton,
Acting Deputy Assistant Secretary for Antidumping and Countervailing
Duty Operations.
[FR Doc. 2025-02542 Filed 2-11-25; 8:45 am]
BILLING CODE 3510-DS-P
</pre></body>
</html>Indexed from Federal Register on February 12, 2025.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.